Literature DB >> 33405200

Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study.

Dislene Nascimento Dos Santos1,2,3, Katia Nunes Sá2, Fernanda C Queirós2, Alaí Barbosa Paixão2, Kionna Oliveira Bernardes Santos2, Rosana Cristina Pereira de Andrade3, Janine Ribeiro Camatti4, Abrahão Fontes Baptista5,6,7,8.   

Abstract

The objective of this study is to describe the chronic pain characteristics in individuals infected with human T cell lymphotropic virus type 1 (HTLV-1) per subgroup (asymptomatic, oligosymptomatic, and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)) compared with controls with chronic pain without HTLV-1. This is a cross-sectional study investigating associations between pain profile, psychopathological symptoms, and quality of life. Individuals infected with HTLV-1 refer high-intensity pain compared with controls, with more severe characteristics being present in oligosymptomatic and HAM/TSP individuals. Oligosymptomatic individuals have a tendency of diffuse and frequent pain, mainly in the head/neck region and more depressive symptoms, resembling nociplastic pain. Neuropathic pain was localized in the lower limbs in all infected groups, worse in HAM/TSP individuals, and associated with a worse perception of quality of life. Pain was associated to higher levels of TNF-alpha and interferon-gamma. HTLV-1 pain is generally more severe when compared with other chronic pain syndromes, being present mainly in the lower limbs. Certain characteristics are typical, depending on the affected group. Oligosymptomatic and HAM/TSP individuals present more diffuse pain, with higher intensity and greater impact in quality of life. Increased levels of inflammatory cytokines are associated with HTLV-1-related pain.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Chronic pain; HTLV-1; Myelopathy; Quality of life

Mesh:

Year:  2021        PMID: 33405200     DOI: 10.1007/s13365-020-00914-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  37 in total

1.  HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics.

Authors:  Inês Dourado; Luiz C J Alcantara; Maurício L Barreto; Maria da Gloria Teixeira; Bernardo Galvão-Castro
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-15       Impact factor: 3.731

Review 2.  The HTLV-1 neurological complex.

Authors:  Abelardo Q C Araujo; Marcus Tulius T Silva
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

3.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

4.  Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.

Authors:  E M Carvalho; O Bacellar; A F Porto; S Braga; B Galvão-Castro; F Neva
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

5.  Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: A cross-sectional study using Respondent Driven Sampling.

Authors:  Cremildo João Baptista; Ines Dourado; Sandra Brignol; Tarcísio de Matos Andrade; Francisco Inácio Bastos
Journal:  Int J Drug Policy       Date:  2016-10-18

6.  Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients.

Authors:  Carlos Maurício de Castro-Costa; Abelardo de Queiroz Campos Araújo; Carlos C Câmara; Ayrton S Ferreira; Terezinha de Jesus T Santos; Samuel Bovy de Castro-Costa; Raimundo Neudson M Alcântara; Graham P Taylor
Journal:  Arq Neuropsiquiatr       Date:  2009-09       Impact factor: 1.420

Review 7.  Role of TNF-alpha during central sensitization in preclinical studies.

Authors:  Pablo Andrade; Veerle Visser-Vandewalle; Carolin Hoffmann; Harry W M Steinbusch; Marc A Daemen; Govert Hoogland
Journal:  Neurol Sci       Date:  2011-05-11       Impact factor: 3.307

8.  Prevalence of Chronic Pain, Treatments, Perception, and Interference on Life Activities: Brazilian Population-Based Survey.

Authors:  Juliana Barcellos de Souza; Eduardo Grossmann; Dirce Maria Navas Perissinotti; Jose Oswaldo de Oliveira Junior; Paulo Renato Barreiros da Fonseca; Irimar de Paula Posso
Journal:  Pain Res Manag       Date:  2017-09-26       Impact factor: 3.037

Review 9.  Neuropathic low back pain in clinical practice.

Authors:  R Baron; A Binder; N Attal; R Casale; A H Dickenson; R-D Treede
Journal:  Eur J Pain       Date:  2016-03-02       Impact factor: 3.931

10.  HAM/TSP and major depression: the role of age.

Authors:  Ney Boa-Sorte; Ana Verena Galvão-Castro; Danilo Borba; Renan Barbalho Nunes de Castro Lima; Bernardo Galvão-Castro
Journal:  Braz J Infect Dis       Date:  2015-01-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.